The Biotech Job Board
Built by Scientists
for Scientists

Where Science Careers Launch

XEPTAGEN SpA is engaged in the discovery and validation of novel molecular markers in order to produce innovative diagnostic kits for cancer early detection, monitoring, and evaluation of response to therapy. By exploiting the natural immune response to early stage cancer and the proprietary platform technology Combinatorial Proteomic®, XEPTAGEN has discovered predictive, prognostic and early response tumor markers that lead to an earlier and much more accurate detection of developing carcinomas. Our mission includes creating innovative tools that improve the clinical management of cancer patients.
Marghera Venice, Metropolitan City of Venice, Italy
Inaccurate data? Flag it here.
Open jobs at XEPTAGEN
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.